Axonal Damage and its Significance for the Concept of Neurodegeneration in Multiple Sclerosis

被引:3
|
作者
Recks, M. S. [1 ]
Bader, J. [1 ]
Kaiser, C. C. [2 ]
Schroeter, M. [2 ]
Fink, G. R. [2 ]
Addicks, K. [1 ]
Kuerten, S. [1 ]
机构
[1] Univ Cologne, Inst Anat 1, D-50931 Cologne, Germany
[2] Univ Cologne, Neurol Klin & Poliklin, D-50931 Cologne, Germany
关键词
axonal damage; demyelination; EAE; inflammation; MS; EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; CYTOTOXIC T-LYMPHOCYTES; APPEARING WHITE-MATTER; AUTOIMMUNE ENCEPHALOMYELITIS; MONOCLONAL-ANTIBODY; DEMYELINATION; LESIONS; INJURY; CNS; TRANSPORT;
D O I
10.1055/s-0029-1246014
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
In spite of tremendous scientific effort, the mechanisms underlying multiple sclerosis (MS) still remain to be elucidated. The prevalent pathogenetic concept adheres to the assumption of a strict hierarchical sequence of the triad inflammation, demyelination and axonal damage. However, recent studies have provided evidence that axonal pathology can occur independently of inflammation and demyelination. The present article critically re-evaluates the traditional paradigm of MS pathology. Potential cellular, humoral and metabolic mechanisms of axonal pathology are delineated and the development of isolated axonal damage is assessed. A better understanding of the pathological processes underlying MS is likely to result in an improvement of current therapeutic strategies. These should not only target the inflammatory, but also the neurodegenerative component of the disease.
引用
收藏
页码:161 / 170
页数:10
相关论文
共 50 条
  • [31] Immunosuppressive therapy reduces axonal damage in progressive multiple sclerosis
    Axelsson, Markus
    Malmestrom, Clas
    Gunnarsson, Martin
    Zetterberg, Henrik
    Sundstrom, Peter
    Lycke, Jan
    Svenningsson, Anders
    MULTIPLE SCLEROSIS JOURNAL, 2014, 20 (01) : 43 - 50
  • [32] Main Role of Antibodies in Demyelination and Axonal Damage in Multiple Sclerosis
    Munoz, Ursula
    Sebal, Cristina
    Escudero, Esther
    Esiri, Margaret
    Tzartos, John
    Sloan, Carolyn
    Sadaba, Mari Cruz
    CELLULAR AND MOLECULAR NEUROBIOLOGY, 2022, 42 (06) : 1809 - 1827
  • [33] Immunosuppressive therapy reduces axonal damage in progressive multiple sclerosis
    Axelsson, M.
    Malmestrom, C.
    Gunnarsson, M.
    Zetterberg, H.
    Sundstrom, P.
    Lycke, J.
    Svenningsson, A.
    MULTIPLE SCLEROSIS JOURNAL, 2013, 19 (11) : 543 - 543
  • [34] Axonal damage in multiple sclerosis: a complex issue in a complex disease
    Grigoriadis, N
    Ben-Hur, T
    Karussis, D
    Milonas, I
    CLINICAL NEUROLOGY AND NEUROSURGERY, 2004, 106 (03) : 211 - 217
  • [35] Neurodegeneration in multiple sclerosis
    Mey, Gabrielle M.
    Mahajan, Kedar R.
    DeSilva, Tara M.
    WIRES MECHANISMS OF DISEASE, 2023, 15 (01):
  • [36] Neurodegeneration in multiple sclerosis
    Lassmann, H
    JOURNAL OF NEUROLOGY, 2005, 252 : 4 - 4
  • [37] Neurodegeneration in multiple sclerosis
    Lassmann, H
    JOURNAL OF NEUROLOGY, 2005, 252 (09) : 1144 - 1145
  • [38] Comparative Analysis of Neurodegeneration and Axonal Dysfunction Biomarkers in the Cerebrospinal Fluid of Patients with Multiple Sclerosis
    Kulczynska-Przybik, Agnieszka
    Dulewicz, Maciej
    Doroszkiewicz, Julia
    Borawska, Renata
    Litman-Zawadzka, Ala
    Arslan, Daria
    Kulakowska, Alina
    Kochanowicz, Jan
    Mroczko, Barbara
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (14)
  • [40] Acute axonal damage predicts clinical outcome in patients with multiple sclerosis
    Lim, ET
    Sellebjerg, F
    Jensen, CV
    Altmann, DR
    Grant, D
    Keir, G
    Thompson, EJ
    Giovannoni, G
    MULTIPLE SCLEROSIS JOURNAL, 2005, 11 (05) : 532 - 536